Vicky Goh
#89,983
Most Influential Person Now
Researcher
Vicky Goh's AcademicInfluence.com Rankings
Vicky Gohcomputer-science Degrees
Computer Science
#10409
World Rank
#10932
Historical Rank
Artificial Intelligence
#5130
World Rank
#5197
Historical Rank
Database
#7399
World Rank
#7668
Historical Rank
Download Badge
Computer Science
Vicky Goh's Degrees
- Masters Artificial Intelligence Stanford University
Similar Degrees You Can Earn
Why Is Vicky Goh Influential?
(Suggest an Edit or Addition)According to Wikipedia, Vicky Goh is a professor, chair of clinical cancer imaging, and head of cancer imaging department at the King's College London, England, United Kingdom. She joined King's College London in 2011. She is also a consultant radiologist at Guy's and St Thomas' Hospital in London.
Vicky Goh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. (2020) (974)
- Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? (2012) (728)
- Imaging biomarker roadmap for cancer studies (2016) (718)
- Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis (2012) (422)
- Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. (2014) (392)
- Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy? (2013) (384)
- Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. (2013) (380)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (377)
- Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. (2013) (363)
- Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. (2011) (324)
- Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? (2013) (296)
- Leukocyte DNA damage after multi-detector row CT: a quantitative biomarker of low-level radiation exposure. (2007) (227)
- Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography (2012) (203)
- Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013) (192)
- Assessing Radiology Research on Artificial Intelligence: A Brief Guide for Authors, Reviewers, and Readers-From the Radiology Editorial Board. (2019) (180)
- Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. (2013) (179)
- Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer (2014) (174)
- Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. (2014) (172)
- Automated Triaging of Adult Chest Radiographs with Deep Artificial Neural Networks. (2019) (161)
- CT perfusion in oncologic imaging: a useful tool? (2013) (160)
- Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. (2003) (156)
- Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks (2015) (147)
- Dynamic MR imaging of the pelvic floor in asymptomatic subjects. (2000) (147)
- Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. (2006) (144)
- Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis? (2008) (142)
- Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis. (2015) (139)
- Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome (2015) (136)
- Quantitative tumor perfusion assessment with multidetector CT: are measurements from two commercial software packages interchangeable? (2007) (133)
- Imaging Heterogeneity in Lung Cancer: Techniques, Applications, and Challenges. (2016) (115)
- CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies (2010) (113)
- Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy. (2014) (110)
- Radiomics in PET: principles and applications (2014) (106)
- Challenges and Promises of PET Radiomics (2018) (105)
- Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. (2007) (103)
- Functional imaging of colorectal cancer angiogenesis. (2007) (102)
- Guidelines for the use of imaging in the management of patients with myeloma (2017) (98)
- Differentiation between diverticulitis and colorectal cancer: quantitative CT perfusion measurements versus morphologic criteria--initial experience. (2007) (97)
- Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. (2008) (96)
- Imaging tumor angiogenesis: functional assessment using MDCT or MRI? (2006) (90)
- Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study (2008) (89)
- Learning to detect chest radiographs containing pulmonary lesions using visual attention networks (2017) (88)
- Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. (2007) (88)
- Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? (2006) (86)
- Novel oncologic drugs: what they do and how they affect images. (2011) (81)
- Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer. (2007) (80)
- Quantitative Colorectal Cancer Perfusion Measurement Using Dynamic Contrast-Enhanced Multidetector-Row Computed Tomography: Effect of Acquisition Time and Implications for Protocols (2005) (79)
- Quantitative assessment of tissue perfusion using MDCT: comparison of colorectal cancer and skeletal muscle measurement reproducibility. (2006) (76)
- Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. (2015) (74)
- Investigating Vulnerable Atheroma Using Combined 18F-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation (2011) (73)
- The precision of textural analysis in 18F-FDG-PET scans of oesophageal cancer (2015) (72)
- The role of functional imaging in colorectal cancer. (2010) (72)
- Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Multidisciplinary Management (2017) (71)
- IntAct: intra‐operative fluorescence angiography to prevent anastomotic leak in rectal cancer surgery: a randomized controlled trial (2018) (71)
- Quantitative assessment of colorectal cancer perfusion using MDCT: inter- and intraobserver agreement. (2005) (71)
- Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment (2016) (71)
- Multifunctional Imaging Signature for V-KI-RAS2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations in Colorectal Cancer (2014) (69)
- Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here (2015) (64)
- Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis (2009) (62)
- UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer (2017) (61)
- Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features (2017) (59)
- Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? (2010) (57)
- The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma (2014) (56)
- Polyp detection with CT colonography: primary 3D endoluminal analysis versus primary 2D transverse analysis with computer-assisted reader software. (2006) (56)
- Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck. (2012) (55)
- Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany (2016) (54)
- Imaging for the diagnosis and response assessment of renal tumours (2018) (51)
- Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. (2012) (51)
- Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine? (2015) (50)
- Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. (2018) (50)
- The therapeutic impact of abdominal ultrasound in patients with acute abdominal symptoms. (2002) (50)
- Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis (2011) (49)
- Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? (2012) (48)
- Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data. (2020) (47)
- Molecular imaging of hypoxia in non-small-cell lung cancer (2015) (47)
- Radiomics in esophageal and gastric cancer (2018) (47)
- Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy (2013) (47)
- The effects of segmentation algorithms on the measurement of 18F-FDG PET texture parameters in non-small cell lung cancer (2017) (46)
- Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany (2017) (46)
- Biomarkers in anal cancer: from biological understanding to stratified treatment (2016) (46)
- Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: implications for helical volumetric perfusion CT techniques. (2008) (45)
- The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus (2016) (45)
- Perfusion CT imaging of treatment response in oncology. (2015) (43)
- Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial (2019) (42)
- Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) in patients with myeloma: Systematic review of diagnostic performance. (2018) (40)
- The role of new PET tracers for lung cancer. (2016) (40)
- Quantitative colorectal cancer perfusion measurement by multidetector-row CT: does greater tumour coverage improve measurement reproducibility? (2006) (40)
- Correlation of Intra-Tumor 18F-FDG Uptake Heterogeneity Indices with Perfusion CT Derived Parameters in Colorectal Cancer (2014) (38)
- Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial (2019) (38)
- PET/MRI in Oncological Imaging: State of the Art (2015) (36)
- Reproducibility of dynamic contrast-enhanced MR imaging: why we should care. (2013) (35)
- Reproducibility of 2D and 3D fractal analysis techniques for the assessment of spatial heterogeneity of regional blood flow in rectal cancer. (2012) (35)
- Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Anal Cancer (2017) (34)
- Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer (2011) (34)
- Hidradenitis Suppurativa: MRI Features in Anogenital Disease (2014) (33)
- Learning to detect chest radiographs containing lung nodules using visual attention networks (2017) (32)
- The Flow–Metabolic Phenotype of Primary Colorectal Cancer: Assessment by Integrated 18F-FDG PET/Perfusion CT with Histopathologic Correlation (2012) (31)
- Non-invasive classification of non-small cell lung cancer: a comparison between random forest models utilising radiomic and semantic features (2019) (31)
- Local radiological staging of rectal cancer. (2004) (31)
- Perfusion CT imaging of colorectal cancer. (2014) (30)
- Imaging assessment of desmoid tumours in familial adenomatous polyposis: is state-of-the-art 1.5 T MRI better than 64-MDCT? (2012) (30)
- Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum (2015) (28)
- Optimizing bowel preparation for multidetector row CT colonography: effect of Citramag and Picolax. (2003) (28)
- Angiogenesis in non-small cell lung cancer: imaging with perfusion computed tomography. (2010) (28)
- Imaging biomarkers in oncology: Basics and application to MRI (2018) (28)
- Imaging breast cancer response during neoadjuvant systemic therapy (2005) (27)
- Heterogeneity in tumours: Validating the use of radiomic features on 18F-FDG PET/CT scans of lung cancer patients as a prognostic tool. (2019) (27)
- Primary colorectal cancer: use of kinetic modeling of dynamic contrast-enhanced CT data to predict clinical outcome. (2013) (27)
- Molecular Imaging of Bone Metastases and Their Response to Therapy (2020) (26)
- Adaptive statistical iterative reconstruction (ASIR) affects CT radiomics quantification in primary colorectal cancer (2019) (26)
- The Impact of the COVID-19 Pandemic on the Radiology Research Enterprise: Radiology Scientific Expert Panel (2020) (25)
- Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview (2016) (25)
- Automated Triaging of Adult Chest Radiographs with Deep Artificial Neural Networks. (2019) (25)
- Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging (2018) (24)
- Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: Implications for radiotherapy planning. (2014) (24)
- CT coronary angiography: Quantitative assessment of myocardial perfusion using test bolus data–initial experience (2008) (23)
- Novel imaging techniques in staging oesophageal cancer. (2018) (23)
- Therapeutic impact of abdominopelvic computed tomography in patients with acute abdominal symptoms (2004) (22)
- The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal (2017) (22)
- Rectal Cancer Magnetic Resonance Imaging: Imaging Beyond Morphology. (2016) (22)
- The challenges of integrating molecular imaging into the optimization of cancer therapy. (2011) (21)
- Texture analysis of 125I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response (2015) (21)
- Meta‐analysis of the prevalence of renal cancer detected by abdominal ultrasonography (2017) (21)
- Pelvic MRI for guiding treatment decisions in rectal cancer. (2014) (21)
- Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L) (2017) (21)
- The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. (2013) (20)
- Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment (2019) (20)
- BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC) (2018) (20)
- Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of 18F-FDG PET (2017) (19)
- MRI of anal cancer: assessing response to definitive chemoradiotherapy (2014) (19)
- Radiomic analysis for response assessment in advanced head and neck cancers, a distant dream or an inevitable reality? A systematic review of the current level of evidence. (2020) (19)
- Quantitative Imaging Biomarkers from PET-CT as potential correlates for angiogenesis and hypoxia in colorectal cancer (2012) (18)
- Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies. (2019) (18)
- Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer. (2010) (17)
- Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters. (2012) (17)
- Clinical and cost implications of using immediate MRI in the management of patients with a suspected scaphoid fracture and negative radiographs results from the SMaRT trial (2019) (17)
- Perfusion CT assessment of the colon and rectum: feasibility of quantification of bowel wall perfusion and vascularization. (2012) (16)
- Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography. (2009) (16)
- Diffusion tensor imaging of the anal canal at 3 tesla: Feasibility and reproducibility of anisotropy measures (2012) (16)
- Effect of intravenous contrast agent volume on colorectal cancer vascular parameters as measured by perfusion computed tomography. (2009) (16)
- The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1 (2017) (16)
- Functional and Hybrid Imaging of Bone Metastases (2018) (16)
- Functional imaging techniques in hepatocellular carcinoma (2012) (15)
- Water–fat separation in diffusion‐weighted EPI using an IDEAL approach with image navigator (2015) (15)
- Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method (2012) (14)
- Characterization of Small Renal Tumors With Magnetic Resonance Elastography: A Feasibility Study (2018) (14)
- Functional imaging of the liver. (2013) (13)
- Does measurement of 18F-fluoride metabolic flux improve response assessment of breast cancer bone metastases compared with standardised uptake values in 18F-fluoride PET/CT? (2018) (12)
- Weight-adapted iodinated contrast media administration in abdomino-pelvic CT: Can image quality be maintained? (2018) (12)
- Accelerated 3D T2 mapping with dictionary‐based matching for prostate imaging (2018) (12)
- Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study (2017) (12)
- Investigating the histopathologic correlates of 18F-FDG PET heterogeneity in non-small-cell lung cancer (2018) (12)
- A Role for FDG PET Radiomics in Personalized Medicine? (2020) (12)
- Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer (2019) (12)
- Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV? (2018) (11)
- Loco-regional staging of malignant pleural mesothelioma by integrated 18F-FDG PET/MRI. (2019) (11)
- What can artificial intelligence teach us about the molecular mechanisms underlying disease? (2019) (11)
- Predicting response to neoadjuvant chemotherapy in primary breast cancer using volumetric helical perfusion computed tomography: a preliminary study (2012) (11)
- Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course (2016) (10)
- Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course (2016) (10)
- Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice. (2017) (10)
- Radiotherapy in Practice - Imaging (2010) (10)
- Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck. (2012) (10)
- Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer. (2016) (10)
- MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer. (2019) (9)
- Imaging Tumor Response and Tumoral Heterogeneity in Non–Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity Analysis (2015) (9)
- How to Select for Preoperative Short-course Radiotherapy, While Considering Long-course Chemoradiotherapy or Immediate Surgery, and Who Benefits? (2014) (9)
- Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment (2018) (9)
- The economic evidence for advanced imaging in the diagnosis of suspected scaphoid fractures: systematic review of evidence (2018) (9)
- Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma (2021) (9)
- Can Combined 18F-FDG-PET and Dynamic Contrast-Enhanced MRI Predict Behavior of Desmoid Tumors in Patients With Familial Adenomatous Polyposis? (2012) (8)
- Systematic review of research design and reporting of imaging studies applying convolutional neural networks for radiological cancer diagnosis (2021) (8)
- Adaptive statistical iterative reconstruction improves image quality without affecting perfusion CT quantitation in primary colorectal cancer (2017) (8)
- Heterogeneity of 18F-FDG PET uptake: Association with treatment response and prognosis in non-small cell lung cancer treated with erlotinib. (2015) (7)
- Measurement of 18F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model (2019) (7)
- Accelerated 3D T2w‐imaging of the prostate with 1‐millimeter isotropic resolution in less than 3 minutes (2019) (7)
- Functional imaging of tumors. Part 1 (2010) (7)
- PET/MRI-knocking on the doors of the rich and famous. (2017) (7)
- Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer. (2016) (7)
- Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUVmax in [18F]fluoride and [18F]FDG PET? (2018) (7)
- Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial (2022) (6)
- Cost-Effectiveness of Immediate Magnetic Resonance Imaging In the Management of Patients With Suspected Scaphoid Fracture: Results From a Randomized Clinical Trial. (2020) (6)
- Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging. (2016) (6)
- Functional computed tomography imaging. (2012) (6)
- CT Tumoral Heterogeneity as a Prognostic Marker in Primary Esophageal Cancer Following Neoadjuvant Chemotherapy. (2013) (6)
- Volumetric perfusion CT assessment of concurrent combretastatin-A4-phosphate (CA4P) and radiotherapy (RT) in non-small cell lung cancer (2008) (5)
- PWE-067 MRI to distinguish hidradenitis suppurativa from perianal Crohn's disease (2012) (5)
- Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). (2014) (5)
- National survey of imaging practice for suspected or confirmed plasma cell malignancies (2018) (5)
- 18F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer. (2022) (5)
- A new presentation of angiopathy in neurofibromatosis type 1 (2000) (5)
- Diffusion tensor imaging (DTI) of desmoid tumours in familial adenomatous polyposis: initial experience. (2012) (5)
- Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus (2019) (4)
- Automatic region-of-interest segmentation and registration of dynamic contrast-enhanced images of colorectal tumors (2014) (4)
- Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma (2020) (4)
- Imaging in the investigation and management of Staphylococcus aureus bacteraemia: A role for advanced imaging techniques. (2020) (4)
- Quality control within the multicentre perfusion CT study of primary colorectal cancer (PROSPeCT): results of an iodine density phantom study (2014) (4)
- Imaging assessment after SBRT for hepatocellular carcinoma (2020) (4)
- Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimens. (2022) (4)
- Imaging Assessment of Lung Tumor Angiogenesis: Insights and Innovations (2014) (4)
- Management of chronic headache with referral from primary care to direct access to MRI compared with Neurology services: an observational prospective study in London (2020) (4)
- A multi-channel uncertainty-aware multi-resolution network for MR to CT synthesis (2021) (4)
- Rationale and design of the SMaRT trial: A randomised, prospective, parallel, non-blinded, one-centre trial to evaluate the use of magnetic resonance imaging in acute setting in patients presenting with suspected scaphoid fracture (2018) (4)
- Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography. (2009) (4)
- Apparent diffusion coefficient agreement and reliability using different region of interest methods for the evaluation of head and neck cancer post chemo-radiotherapy (2021) (4)
- Added Value of Contrast‐Enhanced T1‐Weighted and Diffusion‐Weighted Sequences for Characterization of Incidental Findings on Whole Body Magnetic Resonance Imaging in Plasma‐Cell Disorders (2018) (4)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (3)
- Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI (2021) (3)
- Target Volume Definition in Radiation Oncology (2015) (3)
- The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status (2021) (3)
- Positron Emission Tomography/Magnetic Resonance Imaging of Gastrointestinal Cancers. (2016) (3)
- Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas (2022) (3)
- Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma? (2021) (3)
- Post Brexit: challenges and opportunities for radiology beyond the European Union. (2017) (3)
- Predictors of patient preference for either whole body magnetic resonance imaging (WB‐MRI) or CT/ PET‐CT for staging colorectal or lung cancer (2020) (3)
- RETRACTED ARTICLE: Inter- and intraobserver agreement of the quantitative assessment of [99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer (2020) (3)
- Imaging for staging and response assessment in rectal cancer (2009) (3)
- Correlations between DW‐MRI and 18F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy (2021) (3)
- Imaging in myeloma: a Royal College of Radiologists national survey of current imaging practice. (2021) (2)
- Integrated slice-specific dynamic shimming for whole-body diffusion-weighted MR imaging at 1.5 T (2020) (2)
- Water-fat separation in diffusion-weighted MRI using an EPI-IDEAL approach (2012) (2)
- Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy12 (2017) (2)
- Perfusion CT: Principles, Technical Aspects and Applications in Oncology (2014) (2)
- Is direct radiologist supervision of abdominal computed tomography (CT) scans necessary? (2005) (2)
- Functional imaging of the bowel (2013) (2)
- Synthesis and in vivo evaluation of PEG-BP–BaYbF5 nanoparticles for computed tomography imaging and their toxicity (2020) (2)
- Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry (2019) (2)
- The National Institute for Health Research: making an impact in imaging research. (2019) (2)
- Uncertainty-Aware Multi-resolution Whole-Body MR to CT Synthesis (2020) (2)
- A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus. (2020) (2)
- Professional development and research are being neglected: a commentary on the 2019 RCR radiologists' supporting professional activities (SPA) survey. (2020) (2)
- The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient (2021) (2)
- Cross Attention Transformers for Multi-modal Unsupervised Whole-Body PET Anomaly Detection (2023) (2)
- Imaging assessment of desmoid tumours in familial adenomatous polyposis: is state of the art 1.5T MRI better than 64-MDCT? (2012) (2)
- [Functional imaging of tumors. Part 1]. (2010) (2)
- The acute physiological effects of the vaso-active drug, L-NNA, a nitric oxide synthase inhibitor, on renal and tumour perfusion in human subjects (2014) (2)
- Improved 3D tumour definition and quantification of uptake in simulated lung tumours using deep learning (2022) (2)
- Reply: Relevance of Measurement Uncertainty for Quantitative Response Assessment of Breast Cancer Bone Metastases with 18F-Fluoride (2019) (2)
- Predicting Growth Kinetics in Hereditary Renal Cancer with Diffusion-weighted MRI. (2020) (1)
- Current pressure on the UK imaging workforce deters imaging research in the NHS and requires urgent attention. (2022) (1)
- Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). (2014) (1)
- An observational study to compare the utilisation of computed tomography colonography with optical colonoscopy as the first diagnostic imaging tool in patients with suspected colorectal cancer. (2020) (1)
- Characterisation of solid renal tumours with magnetic resonance elastography (MRE) at 3T: Integrating biomechanical, morphological and functional assessment (2017) (1)
- PO-0707: Magnetic Resonance Imaging Texture Analysis Parameters for predicting risk of Anal Cancer recurrence (2017) (1)
- PP086-SUN: Outstanding abstract: Body Composition and Association with Treatment Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving Targeted Agents (2014) (1)
- Fluorodeoxyglucose positron‐emission tomography (FDG PET)/computed tomography (CT) in bladder cancer (2013) (1)
- Radiomic Analysis of Tumour Heterogeneity Using MRI in Head and Neck Cancer Following Chemoradiotherapy: A Feasibility Study (2022) (1)
- Sparse Regression in Cancer Genomics: Comparing Variable Selection and Predictions in Real World Data (2021) (1)
- Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase (2022) (1)
- Correlation between whole skeleton dual energy CT calcium-subtracted attenuation and bone marrow infiltration in multiple myeloma (2022) (1)
- Review: Functional and hybrid imaging of bone metastases (2018) (1)
- Bevacizumab and combination chemotherapy in rectal cancer until surgery (BACCHUS): A phase II, multicenter, open-label, randomized study of neoadjuvant chemotherapy alone without radiation in patients with MRI-defined high-risk cancer of the rectum not threatening the circumferential margin. (2014) (1)
- Occupational radiation exposure in doctors: an analysis of exposure rates over 25 years. (2021) (1)
- Imaging for common complications (2010) (1)
- [Functional imaging of tumors. Part 2]. (2010) (1)
- MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response? (2021) (1)
- Reply to letter to the editor: Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis (2009) (1)
- EP-1277: Optimising RT dose for anal cancer - the development of three clinical trials in one platform (2017) (1)
- LBA28 STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC) (2021) (1)
- Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population (2022) (0)
- 18F-FDG PET/CT and whole-body MRI in assessing newly diagnosed myeloma- concordance between functional imaging markers of disease (2019) (0)
- Multiparametric MRI assessment during cisplatin and trastuzumab therapy in esophageal adenocarcinoma xenografts. (2015) (0)
- PIT10 COST AND COST-EFFECTIVENESS IMPLICATIONS OF UTILIZING IMMEDIATE ACUTE MAGNETIC RESONANCE IMAGING IN THE MANAGEMENT OF PATIENTS WITH SUSPECTED SCAPHOID FRACTURE AND NEGATIVE INITIAL RADIOGRAPHS: RESULTS FROM A RANDOMIZED CLINICAL TRIAL IN THE UNITED KINGDOM. (2019) (0)
- Is a PET/MRI scan better than a PET/CT scan at visualising bone lesions and their change with treatment in adults with myeloma? (2020) (0)
- Arterial Spin Labeled Perfusion MRI for Assessing Antiangiogenic Therapy: A Step Forward or Just More Spin? (2020) (0)
- Body composition and association with treatment toxicity in patients with advanced renal cell carcinoma receiving targeted agents. (2013) (0)
- EP-1425 MRI heterogeneity analysis for predicting response to neoadjuvant therapy in oesophageal cancer (2019) (0)
- Tumor heterogeneity in anal cancer assessed with diffusion-weighted (DW) and T2-weighted MRI: Potential biomarker of treatment outcome. (2017) (0)
- A Prospective Study of Bevacizumab and Platinum-Based Chemotherapy in NSCLC: Comparison of the Prognostic Value of Early Imaging Response Assessment Criteria and Intratumoral Heterogeneity Analysis (2014) (0)
- F-FDG PET / CT ) in patients with myeloma : Systematic review of diagnostic performance and impact on management 1 , 2 (2018) (0)
- Intratumoral Voxel Heterogeneity as a Potential Response Biomarker : Assessment in a HER 2 + Esophageal Adenocarcinoma Xenograft Following Trastuzumab and / or Cisplatin Therapy 1 (2017) (0)
- F-FDG PET texture parameters in non-small cell lung cancer (2017) (0)
- Pretreatment FDG PET Tumor Heterogeneity in Non-small Cell Lung Cancer is Associated With Poor Response and Survival Following Chemoradiation Therapy (2012) (0)
- Quantitative Assessment of Colorectal Cancer Perfusion: Perfusion Computed Tomography and Dynamic Contrast Enhanced Magnetic Resonance Imaging (2009) (0)
- Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study (2017) (0)
- SP-0110: Imaging markers for response prediction: the clinical need (2016) (0)
- Editorial Comment: Artificial Intelligence for Lung Nodules-Progress, But Is It Enough? (2022) (0)
- CT Tumor Heterogeneity in Prognostication of Primary Esophageal Cancer Treated With Definitive Chemoradiation (2012) (0)
- Effects of body composition as measured by CT on clinical outcomes in patients with oesophageal cancer (2015) (0)
- 890P Prospective comparison of RECIST and alternative response assessment criteria in the evaluation of metastatic renal cell cancer patients from phase II of the multi-centre randomised STAR trial. (2017) (0)
- Perfusion CT: Technical Aspects (2017) (0)
- Contrast-enhanced mR imaging: Why We Should Care 1 (2013) (0)
- Changes in body composition in primary oesophageal cancer: does it affect immediate and long-term clinical outcomes? (2013) (0)
- Multimodality multiparametric assessment of bone metastases in prostate and breast cancer: 18F-Fluoride, 11C-Choline, 18F-FDG PET/CT and DW-MRI (2014) (0)
- Measurement of Angiogenesis: CT Principles and Practice (2009) (0)
- 9.4T-MRI assessment during Cisplatin and Trastuzumab therapy in oesophageal adenocarcinoma xenografts (2015) (0)
- PO-0774: Role of Magnetic Resonance Imaging in radiotherapy target volume definition in Oesophageal Cancer (2018) (0)
- Research should remain a priority in 21st century radiology recruitment to training (2023) (0)
- NIHR Imaging Group. Who are we and what do we do? (2023) (0)
- Role of F-18 FLT PET-CT as a Predictive Biomarker in ASS1-Deficient Thoracic Cancers Treated with Pegargiminase (2022) (0)
- 926: Application of texture analysis to SPECT images of 125I-A5B7 anti-CEA antibody localisation in metastatic colorectal cancer models: Correlation with histological microarchitecture and response to antivascular therapy (2014) (0)
- Whole body dual energy CT in detection and staging of myeloma; technical aspects and clinical applications. (2020) (0)
- Corrigendum to “Is there a role for perfusion imaging in assessing treatment response following ablative therapy of small renal masses—A systematic review” [Eur. J. Radiol. Open 5 (2018) 102–107] (2019) (0)
- P-178 Diffusion-weighted magnetic resonance imaging as an early predictive marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data meta-analysis (2022) (0)
- 163 Phase I clinical trial of N-nitro-L-arginine (LNNA): Pharmacokinetics, toxicities and effects on microregional blood flow (2006) (0)
- P1.03-024 Accuracy of Combined Semantic and Computational CT Features in Predicting Non-Small Cell Lung Cancer Subtype: Topic: Radiology (2017) (0)
- State-of-the-art imaging in oesophago-gastric cancer. (2022) (0)
- Baseline 18F-FDG-PET and Dynamic Contrast Enhanced (DCE)-MRI for assessment of lymph node metastatic potential of oesophageal adenocarcinoma. (2019) (0)
- Correlation of 18F-FDG-PET/CT metabolic parameters with PD-L1 tumour proportion score (TPS) in resected non-small cell lung cancer (NSCLC) (2021) (0)
- Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy 1,2 (2017) (0)
- An Incidental Renal Oncocytoma: 18F-Choline PET/MRI (2016) (0)
- 9012 Volumetric helical perfusion CT and FDG-PET/CT as prognostic biomarkers in operable non-small cell lung cancer: correlation with clinico-pathological parameters (2009) (0)
- Prostate Cancer: Radiological Imaging (2017) (0)
- PI-RADS and Multiparametric MRI: The Shape of Things to Come for Prostate Cancer. (2023) (0)
- Imaging of tumour heterogeneity: Functional MR techniques in oncology (2018) (0)
- CT response assessment combining reduction in size and arterial enhancement correlates with time to progression in metastatic renal cancer patients treated with TKIs. (2009) (0)
- CT-based predictive model for circumferential resection margin in oesophageal cancer (2013) (0)
- Primary Esophageal Cancer Heterogeneity as a Potential Prognostic Biomarker in Patients Treated with Definitive Chemoradiation (2014) (0)
- Pathological heterogeneity after trastuzumab and combination chemotherapy in HER2+ gastroesophageal adenocarcinoma xenograft. (2016) (0)
- Imaging symptomatic carotid plaque with dynamic contrast enhanced MRI (DCE-MRI) at 3Tesla and 18F-FDG PET/CT: Histological correlation (2009) (0)
- Tumor Physiology and Clinically Significant Prostate Cancer Detection. (2022) (0)
- CT Prognostication in Esophageal Cancer Treated With Definitive Chemoradiation Is Still Relevant (2012) (0)
- 1161P Can 18F-FDG-PET/CT predict PD-L1 expression in resected non-small cell lung cancer (NSCLC)? (2021) (0)
- PO-0788: MR imaging biomarkers for prediction of response to neoadjuvant treatment in oesophageal cancer (2018) (0)
- Perfusion CT Imaging in Oncology (2015) (0)
- Brain metastases in a large UK Cancer Centre: Trends over a decade, 2000 to 2010 (2013) (0)
- Dynamic Contrast-Enhanced and Diffusion-Weighted MRI of the Gastrointestinal Tract (2010) (0)
- Functional & morphological plaque 3T MRI & 18F FDG PET/CT: Histological validation (2009) (0)
- Perfusion Computed Tomography and its Application in Oncologic Practice (2013) (0)
- Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma (2019) (0)
- Is there a role for perfusion imaging in assessing treatment response following ablative therapy of small renal masses—A systematic review☆ (2018) (0)
- of heterogeneity in of F-FDG PET in (2018) (0)
- Multiparametric MRI (mpMRI) assessment of renal masses with histopathological correlation using established and emerging sequences (2016) (0)
- Attracting the next generation of radiologists: a statement by the European Society of Radiology (ESR) (2022) (0)
- PTH-092 Interval Scanning with Magnetic Resonance Enterography Demonstrates Response to Anti-Tnf Therapy and has Utility in Reassessment of Crohn’S Disease (2013) (0)
- Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up (2014) (0)
- 1011 POSTER The effects of tumour volume coverage on the assessment of vascular activity following radiotherapy in human non-small cell lung cancer using dynamic contrast enhanced computed tomography (2007) (0)
- Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. (2023) (0)
- The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic (2019) (0)
- P-284 Exploratory magnetic resonance imaging histogram biomarkers for response prediction to neoadjuvant treatment in oesophageal/gastro-oesophageal cancer (2021) (0)
- SO-14 Baseline diffusion-weighted magnetic resonance imaging features to predict recurrence of anal squamous cell carcinoma following chemoradiotherapy (2020) (0)
- Role of molecular functional imaging in present era of evidence based cancer medicine: to image or to imagine? (2015) (0)
- A prospective study of diffusion-weighted magnetic resonance imaging for predicting outcome following chemoradiotherapy, in squamous cell carcinomas of the anus (2019) (0)
- Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum (2015) (0)
- The prevalence of renal cancer detected by abdominal ultrasonography in asymptomatic individuals: A systematic review and meta-analysis to inform the case for a screening study (2017) (0)
- Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L) (2017) (0)
- Diffusion weighted imaging of carotid atherosclerotic plaque in symptomatic patients at 3-tesla: Correlation with MRI, CT & histopathological predictors of plaque vulnerability (2010) (0)
- Baseline Diffusion Weighted Magnetic Resonance Imaging to Predict Recurrence of Anal Squamous Cell Carcinoma (ASCC) Following Chemoradiotherapy (2019) (0)
- Assessing the Performance of Automated Prediction and Ranking of Patient Age from Chest X-rays Against Clinicians (2022) (0)
- iSmaRT: Imaging small renal tumours (2019) (0)
- Principles of imaging (2010) (0)
- Radiomics analysis in cancer of the gastro-oesophageal junction: 18F-FDG-PET/MRI-derived quantitative features are associated with M-stage (2018) (0)
- Oncogene Homolog ( KRAS ) Mutations in Colorectal Cancer Multifunctional Imaging Signature for V-KI-RAS 2 Kirsten Rat Sarcoma Viral (2014) (0)
- Economic Sanctions Endanger Nuclear Medicine Services in Iran (2019) (0)
- Functional imaging of tumors. Part 2 (2010) (0)
- Academic clinical fellows in radiology: how can we improve success? (2023) (0)
- Novel imaging techniques in staging oesophageal cancer FINAL (2018) (0)
- Towards quantitative follow-up for anatomical and functional whole-body MRI (2018) (0)
- PO-0989: Hypoxic and perfusion effects of Trastuzumab in a HER2+ oesophageal adenocarcinoma xenograft model (2016) (0)
- ASO Visual Abstract: Clinical Relevance of the Tumor Location-Modified Laurén Classification System of Gastric Cancer in a Western Population (2022) (0)
- The Role of Magnetic Resonance Imaging in the Management of Anogenital Hidradenitis Suppurativa (2016) (0)
- Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT (2022) (0)
- CT response assessment combining reduction in size and arterial enhancement correlates with time to progression in metastatic renal cancer patients treated with TKIs (2009) (0)
- Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus. (2020) (0)
- Distortion‐free 3D diffusion imaging of the prostate using a multishot diffusion‐prepared phase‐cycled acquisition and dictionary matching (2020) (0)
- Bone metastases in prostate cancer: which scan? (2014) (0)
- Assessment of the metabolic-perfusion relationship in primary colorectal adenocarcinoma using integrated 18- FDG PET/CT and perfusion CT (2008) (0)
- Undergraduate radiology education in Europe in 2022: a survey from the European Society of Radiology (ESR) (2023) (0)
- 2107 Imaging assessment of the in vivo metabolic-vascular relationship of primary colorectal cancer by integrated 18-FDG PET/Perfusion CT – feasibility and validation with immunohistochemical markers of angiogenesis and hypoxia (2009) (0)
- A gap analysis for breast cancer research: identifying translational priorities (2013) (0)
- Erratum to "The National Institute for Health Research: making an impact in imaging research" [74 (3) 242-246]. (2019) (0)
- SP-0686 For the radiologist: How AI has impacted radiology (2022) (0)
- Spanish translation section (2018) (0)
- SP2.2.5 Sarcopenia and lymphopenia in patients undergoing chemotherapy and surgery for oesophageal cancer. Can prehabilitive exercise be used to reverse the decline? (2022) (0)
- Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma (2023) (0)
- Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer (2021) (0)
- P418 Magnetic resonance enterography demonstrates response to anti-TNF therapy in small bowel Crohn's disease (2013) (0)
- Bailey MIB 2015 (2015) (0)
- Assessment of tumoral heterogeneity in NSCLC treated with bevacizumab: A prospective study. (2014) (0)
- Temporal Evolution of Hepatic Fat Distribution Heterogeneity using Dynamic 18F-FDG PET Imaging (2015) (0)
- 173TiP PECan Study, Imaging PD-L1 in Cancer: A Tool for Measuring Response to Immunotherapy? (2019) (0)
- Hypoxic and perfusion effects of Trastuzumab in a HER 2 + oesophageal adenocarcinoma xenograft model (2016) (0)
- Functional imaging and emerging techniques in CT (2020) (0)
- Tu1128 Magnetic Resonance Enterography Demonstrates Response to Anti-TNF Therapy in Small Bowel Crohn's Disease (2013) (0)
This paper list is powered by the following services:
Other Resources About Vicky Goh
What Schools Are Affiliated With Vicky Goh?
Vicky Goh is affiliated with the following schools:
